from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1442/bisC

LFCtreatmentdescriptionclass of inhibitor

-0.452

Amikacinug/mL Amikacintranslation

0.265

Cap5-10ug/mL Capreomycintranslation

0.235

Rox10-50 ug/mL Roxithromycintranslation

-0.119

SM2-5 ug/mL Streptomycintranslation

-0.254

Tet5-10 ug/mL Tetracyclinetranslation

-2.929

Rif0.2-5ug/mL Rifampicintranscription

-1.702

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.201

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.003

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.580

CPZ10-50 ug/mL Chlorpromazinerespiration

0.799

Clofazimine10-13 ug/mL Clofaziminerespiration

0.241

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.173

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.925

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.343

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.286

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.206

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.515

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.733

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.900

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.085

KCN5-20 ug/mL Potassium cyaniderespiration

-0.045

NaN30.2-2 mM Sodium aziderespiration

-0.648

Nigericin50 uM Nigericinrespiration

-0.893

TRC10-150 ug/mL Triclosanrespiration

1.562

TRZ10-25 ug/mL Thioridazinerespiration

-0.404

Valinomycin0.5-10 uM Valinomycinrespiration

0.514

ZnSO42 mM ZnSO4respiration

0.484

menadione6-10 ug/mL Menadionerespiration

-0.105

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.500

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.118

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.079

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.919

NRP_1Non-replicating persistence stage 1dosRassociated

0.108

Amp0.2mg/mL AmpicillincellWall

-0.158

Cephalexin20-100 ug/mL CephalexincellWall

-0.148

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.315

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.541

EMB10-20 ug/mL EthambutolcellWall

-0.527

Eta12-40 ug/mL EthionamidecellWall

-0.595

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.110

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.549

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.011

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.334

BZA0.12 mg/mL BenzamidearomaticAmides

0.367

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.213

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.711

H2O24 mM hydrogen peroxideDNAdamaging

-0.381

Levo10 ug/mL LevofloxacinDNAdamaging

-0.326

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.054

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.361

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.319

UVUV-irradiationDNAdamaging

0.336

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.455

Antimycin12.5-50 ug/mL Antimycin A?

-0.521

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.265

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.257

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.484

PA8240.2-2 ug/mL PA-824?

-0.115

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.497

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.052

Verapamil50 uM Verapamil?

-0.879

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.318

methoxatin10-20 ug/mL Methoxatin?